Epitalon (also spelled Epithalon, or AEDG) is a synthetic tetrapeptide made of alanine, glutamic acid, aspartic acid and glycine. It was developed in Russia as an analog of the pineal peptide epithalamin and is studied primarily in longevity and gerontology research.

What does research suggest Epitalon does?

Research has proposed effects on telomerase activity and on circadian and pineal function, which is why it is discussed in relation to aging, telomeres and sleep. These remain proposed mechanisms; human evidence is sparse and largely from a small number of research groups, with limited independent replication.

Is Epitalon approved or FDA-approved?

No. Epitalon is not an approved medicine in mainstream regulatory frameworks and is treated internationally as a research chemical rather than a validated treatment. It is not approved by the FDA.

What are the side effects of Epitalon?

The long-term side-effect profile in humans is essentially unknown due to the limited quality of the available research. There is not enough rigorous human data to define a reliable safety or adverse-effect profile.

Epitalon holds research-chemical status rather than status as an approved medicine, and its legality varies by jurisdiction. It is not authorized as a therapeutic product, and this page does not provide sourcing or purchasing guidance.

How is Epitalon related to Epithalamin, and are they the same thing?

No. Epithalamin is a natural polypeptide complex extracted from animal pineal glands and studied first. Epitalon (AEDG) is a short synthetic tetrapeptide developed as a chemically defined stand-in for it. They come from the same Russian research lineage but are different substances, and evidence about one does not automatically transfer to the other.

Why does Epitalon get called a 'telomerase activator' so often?

The label traces back to a small number of cell-culture experiments from the groups that originally developed the peptide, which reported increased telomerase activity in vitro. This is a common point of misunderstanding: an effect seen in cultured cells is not the same as demonstrated anti-aging benefit in living humans, and independent replication of these findings is limited.

Why is so much of the Epitalon research from a single source?

Much of the published work originates from Vladimir Khavinson and affiliated St. Petersburg institutions who developed the compound. When most evidence for a substance comes from the group that created and promotes it, independent replication matters a great deal, and for Epitalon that independent confirmation is largely missing, which is a key reason mainstream reviewers treat the claims cautiously.

Where can I buy Epitalon and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Longevity

Buy Epitalon – Vendors, Prices, Testing and Evidence

Buy Epitalon

Also known as: Epithalon · AEDG

Evidence grade D — Anecdotal

Short answer

A tetrapeptide discussed in longevity circles for telomerase-related claims. Human evidence is weak.

Where can you buy Epitalon?

Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is known?

Epitalon is a synthetic tetrapeptide studied primarily in Russian gerontology research.

What is not established?

Sparse and largely from a small number of research groups; independent replication is limited.

Safety

Human safety data is weak. Claims should be treated with caution.

Regulatory status

Not an approved medicine. Research chemical status.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Vendor comparison

Buy Epitalon: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

Vendor	Product	Documentation	Shipping	Checked	Action
Crystal Peptides Code PEPTIDES10 −10% · discount code details Sponsored	Epitalon research product	Vendor-supplied data COA stated as available Not independently documented	Europe See the localized country store	Jul 18, 2026	View at vendor

Crystal Peptides

Epitalon research product

Code PEPTIDES10 −10% · discount code details

What is it?

Epitalon is a synthetic tetrapeptide studied primarily in Russian gerontology research.

Research and evidence

Epitalon, also spelled Epithalon and known by the amino-acid shorthand AEDG (Ala-Glu-Asp-Gly), is a synthetic tetrapeptide that appears frequently in longevity and anti-aging discussions. It was developed in Russia as a short-chain analog of epithalamin, a peptide extract of the pineal gland, and has been studied primarily within Russian gerontology research. On peptides.cx it is catalogued as a Longevity-category compound, and it is important to be clear from the outset that Epitalon is not an approved medicine anywhere in the mainstream regulatory sense; internationally it is handled as a research chemical rather than a validated therapeutic.

The interest in Epitalon centers on a handful of proposed mechanisms rather than proven outcomes. The most widely cited hypothesis is that it may influence telomerase activity, the enzyme that maintains the protective telomere caps on chromosomes, which is why it is so often linked to telomere and cellular-aging conversations. It is also discussed for possible circadian and pineal-related effects, including melatonin regulation and sleep. These are best understood as proposed or discussed mechanisms, not established facts. The human evidence base is sparse and comes largely from a small number of research groups closely associated with the peptide's origin, and independent replication has been limited. Some rodent studies from those originating groups have reported longevity-related findings, but animal data does not establish that similar effects occur in people.

Anyone researching Epitalon should weigh that honest evidence picture carefully. peptides.cx assigns it a low evidence score reflecting weak human data, and its long-term safety profile in humans is not well characterized. Because research-market material is not subject to pharmaceutical quality control, purity and identity cannot be assumed, and the bold telomerase and life-extension claims circulating online outrun what published research actually supports. This page is an educational reference intended to summarize what Epitalon is and what the evidence does and does not show. It is not medical advice, and it deliberately avoids dosing, protocols, or sourcing guidance.

Evidence grade: D

Sparse and largely from a small number of research groups; independent replication is limited. Some rodent longevity data reported by originating groups.

Human evidence

Sparse and largely from a small number of research groups; independent replication is limited.

Animal and preclinical evidence

Some rodent longevity data reported by originating groups.

Proposed mechanisms

Proposed effects on telomerase activity
Discussed circadian and pineal effects

Safety concerns and known side effects

Human safety data is weak. Claims should be treated with caution.

Unknown long-term profile

Regulatory status

Not an approved medicine. Research chemical status.

Epitalon research timeline

1970s–1980s
Soviet gerontology researchers, led by Vladimir Khavinson, study a pineal-gland extract called Epithalamin, from which Epitalon is later derived.
1980s–1990s
The tetrapeptide Epitalon (Ala-Glu-Asp-Gly / AEDG) is synthesized as a defined 'peptide bioregulator' at the St. Petersburg Institute of Bioregulation and Gerontology.
1990s–2000s
Originating research groups publish rodent studies reporting effects on lifespan, circadian rhythm and tumor incidence, largely without independent replication.
Early 2000s
Cell-culture reports from the same groups propose that Epitalon can induce telomerase activity, the basis for most modern longevity marketing claims.
2010s–2020s
Epitalon spreads through online longevity communities and is sold internationally as a research chemical; no regulator approves it as a medicine and rigorous independent human trials remain absent.

Frequently asked questions about Epitalon

What is Epitalon?: Epitalon (also spelled Epithalon, or AEDG) is a synthetic tetrapeptide made of alanine, glutamic acid, aspartic acid and glycine. It was developed in Russia as an analog of the pineal peptide epithalamin and is studied primarily in longevity and gerontology research.
What does research suggest Epitalon does?: Research has proposed effects on telomerase activity and on circadian and pineal function, which is why it is discussed in relation to aging, telomeres and sleep. These remain proposed mechanisms; human evidence is sparse and largely from a small number of research groups, with limited independent replication.
Is Epitalon approved or FDA-approved?: No. Epitalon is not an approved medicine in mainstream regulatory frameworks and is treated internationally as a research chemical rather than a validated treatment. It is not approved by the FDA.
Is Epitalon safe?: Human safety data for Epitalon is weak and its long-term profile is not well characterized. Because research-market material is not subject to pharmaceutical quality control, purity and identity cannot be assumed, so any claims should be treated with caution.
What are the side effects of Epitalon?: The long-term side-effect profile in humans is essentially unknown due to the limited quality of the available research. There is not enough rigorous human data to define a reliable safety or adverse-effect profile.
Is Epitalon legal?: Epitalon holds research-chemical status rather than status as an approved medicine, and its legality varies by jurisdiction. It is not authorized as a therapeutic product, and this page does not provide sourcing or purchasing guidance.
How is Epitalon related to Epithalamin, and are they the same thing?: No. Epithalamin is a natural polypeptide complex extracted from animal pineal glands and studied first. Epitalon (AEDG) is a short synthetic tetrapeptide developed as a chemically defined stand-in for it. They come from the same Russian research lineage but are different substances, and evidence about one does not automatically transfer to the other.
Why does Epitalon get called a 'telomerase activator' so often?: The label traces back to a small number of cell-culture experiments from the groups that originally developed the peptide, which reported increased telomerase activity in vitro. This is a common point of misunderstanding: an effect seen in cultured cells is not the same as demonstrated anti-aging benefit in living humans, and independent replication of these findings is limited.
Why is so much of the Epitalon research from a single source?: Much of the published work originates from Vladimir Khavinson and affiliated St. Petersburg institutions who developed the compound. When most evidence for a substance comes from the group that created and promotes it, independent replication matters a great deal, and for Epitalon that independent confirmation is largely missing, which is a key reason mainstream reviewers treat the claims cautiously.
Where can I buy Epitalon and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

LongevitySleepTelomeres

Compare Epitalon

Epitalon vs Thymalin

Sources

Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising Properties — PubMed Central

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10